David E.L. Wilcken - Concepedia

Author

David E.L. Wilcken

Also Known As

DAVID E. L. WILCKEN, DAVID E. L. Wilcken, DAVID E.L. WILCKEN, David E L Wilcken, David E. L. Wilcken, David E. L.Wilcken, David E.L Wilcken, David E.L. Wilcken, David EL Wilcken, David WILCKEN

Publications

5.5K

Citations

H-Index

101

Concepts

All Affiliations

Prince of Wales Hospital UNSW Sydney Texas Biomedical Research Institute

About

David E.L. Wilcken is an author at Prince of Wales Hospital specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	3K
2	Public Health	16	18	1.6K
3	Health Sciences	4	4	234
4	Natural Sciences	2	2	84
5	Education	1	1	18

David E.L. Wilcken

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene Xing L. Wang, Ah Siew Sim, Renee F. Badenhop, Nature Medicine Tobacco ControlVascular DiseaseCardiovascular EpidemiologyCardiovascular DiseaseSmoking–dependent Risk	1996	565
The Effect of Weight Reduction on Left Ventricular Mass Stephen MacMahon, David E.L. Wilcken, Graham Macdonald New England Journal of Medicine HypertensionHeart FailureBlood PressureDiastolic FunctionObesity	1986	343
Genetic Contribution of the Endothelial Constitutive Nitric Oxide Synthase Gene to Plasma Nitric Oxide Levels Xing L. Wang, Michael C. Mahaney, Ah Siew Sim, Arteriosclerosis Thrombosis and Vascular Biology	1997	294
Vascular Outcome in Patients With Homocystinuria due to Cystathionine β-Synthase Deficiency Treated Chronically Sufin Yap, Godfried H.J. Boers, Bridget Wilcken, Arteriosclerosis Thrombosis and Vascular Biology	2001	252
Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to Pyridoxine David E.L. Wilcken, Bridget Wilcken, Nicholas P.B. Dudman, New England Journal of Medicine Homocysteine RemethylationMolecular PharmacologyConventional TherapyMedicinePhysiology	1983	249
Nitric oxide induces and inhibits apoptosis through different pathways Ying H. Shen, Xing L. Wang, David E.L. Wilcken FEBS Letters	1998	173
Effects of Alterations in Aortic Impedance on the Performance of the Ventricles David E.L. Wilcken, André A. Charlier, Julien I.E. Hoffman, Circulation Research Cardiac MuscleHealthy Conscious DogsHeart FailureMotor ControlCardiovascular Function	1964	152
Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria David E.L. Wilcken, S. Reddy, Vatsala Gupta Metabolism Cardiovascular DiseaseCarrier StatePhysiologyMedicineAtherosclerosis	1983	135
The Glu-298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease Hua Cai, David E.L. Wilcken, Xing Li Wang Journal of Molecular Medicine Vascular DiseaseCardiovascular DiseasePhysiologyEndothelial DysfunctionMolecular Biology	1999	104
Mitral valve prolapse and bacterial endocarditis: When is antibiotic prophylaxis necessary? Andrew J. Hickey, Stephen MacMahon, David E.L. Wilcken American Heart Journal Antibiotic ProphylaxisMitral Valve ProlapseAntimicrobial StewardshipAntibioticsValve Disease	1985	102

Page 1